+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

FID-ISPAD Diabetes Research Grant 2026

International Society for Pediatric and Adolescent Diabetes (ISPAD)

This grant is for ISPAD members, preferentially below the age of 40.

The scope of the research grant is related to the identification of a cure for type 1 diabetes, defined as a procedure or therapy capable of ensuring normalization and long-term maintenance of normal glucose balance in the absence of external insulin administration.This category includes projects focused on:

Pathogenesis
Prediction
Prevention
Beta-cell replacement
Organ and cell transplantation
Tissue regeneration and stem cells
Gene therapy

Projects dealing with local screening programs for early detection of T1D will receive lower priority compared to projects aiming to identify a definitive cure for T1D.

Explicitly excluded from funding is research on insulin, drugs, glucose sensor technologies, or insulin infusers, which pertain to pharmaceutical and biotechnology companies. Also excluded is research related to complications of diabetes and research related to type 2 diabetes or forms of diabetes other than type 1 diabetes.

FID-ISPAD Research Grant program is only open to applicants from non-profit institutions or groups of such institutions.

All applications will be considered by the Scientific Review Committee, FID and ISPAD in strict confidentiality

The FID-ISPAD Diabetes Research Grant is for 25,000 EUR.

How to apply for the FID-ISPAD research grant

The documents required to apply for the FID-ISPAD Diabetes Research Grant are as follows:

Applicant’s CV
Proof of ISPAD membership
The application procedure includes the completion of a form structured in 6 paragraphs: title, background/rationale, objectives, study design, anticipated outcome, relevance to the cure of type1 diabetes; for a maximum length of 500 words in type no smaller than 12 points Arial with single line spacing.

Please provide the budget breakup and how the funding will be used. If other grants have been received for the project please provide the details.

Approval letter from the institution to which it belongs, which must declare its willingness to accept the funding and use it exclusively for the project being funded, define the so-called 'overhead' (i.e., the percentage retained by the institution, which must not exceed 10%) and ensure access to funding by the recipient.

AI Based Application Success Predictor

1. Strong relevance to pediatric or adolescent diabetes

The most competitive applications directly address:

type 1 diabetes (T1D)
pediatric diabetes management
diabetes prevention
diabetes prediction
beta-cell biology
pediatric diabetes complications
psychosocial aspects of diabetes in youth
diabetes technology in children and adolescents
transition from pediatric to adult diabetes care

ISPAD’s mission is centered on improving outcomes for children, adolescents, and young adults with diabetes.

2. Strong emphasis on type 1 diabetes cure or disease-modifying research

A particularly important ISPAD-specific predictor—especially for the FID-ISPAD Diabetes Research Grant—is relevance to curative approaches for type 1 diabetes, including:

pathogenesis
prediction
prevention
beta-cell replacement
tissue regeneration and stem cells
organ/cell transplantation
gene therapy

Projects focused on identifying a definitive cure for T1D are prioritized over local screening-only studies.

3. Clear translational impact for children with diabetes

Successful proposals usually show potential to:

improve glucose outcomes
reduce disease burden
improve quality of life
improve long-term pediatric outcomes
influence clinical diabetes care
improve access to care globally

Clinical applicability is one of the strongest predictors of competitiveness.

4. Strong methodological rigor

Competitive applications generally demonstrate:

robust clinical or laboratory design
validated outcome measures
clear endpoints
appropriate statistical planning
reproducibility
feasible timelines

Weak methodology is a common reviewer concern across ISPAD-supported programs.

5. Strong early-career investigator profile

Many ISPAD fellowships specifically prioritize:

early-career researchers
trainees
young investigators
applicants typically under 40 years old

Examples include:

ISPAD–Breakthrough T1D Research Fellowship
Visiting Research Fellowship
Young Investigator Award

ISPAD explicitly states preference for members below age 40 in several schemes.

6. Strong mentorship and host-institution support

Competitive fellowship applications often include:

a strong mentor or supervisor
host institution letter of support
recognized diabetes research environment
access to patient populations or research infrastructure

This is particularly important for visiting and clinical fellowship schemes such as the Allan Drash Fellowship.

7. Strong preliminary or pilot data

Applications with:

pilot diabetes datasets
preliminary immunology or beta-cell findings
feasibility studies
prior related publications
proof-of-concept work

typically receive stronger reviewer confidence.

8. International collaboration and global relevance

ISPAD is highly international, so strong applications often demonstrate:

multinational collaboration
applicability beyond one healthcare setting
relevance for diverse pediatric populations
potential to improve care globally

Global pediatric diabetes benefit is highly valued.

9. Clear career-development potential

For fellowships, reviewers strongly assess:

long-term academic trajectory
future leadership in pediatric diabetes
research independence
contribution to the international diabetes community

ISPAD’s science schools and fellowship programs are designed specifically to build future leaders in pediatric diabetes research.

10. Potential for publication and future funding

Reviewers favor projects likely to:

generate high-quality publications
support larger NIH/JDRF/EASD/EFSD grants
develop long-term pediatric diabetes programs
lead to future clinical trials or multicenter collaborations

Common Reasons for Rejection

Frequent reviewer concerns include:

weak relevance to pediatric diabetes
insufficient type 1 diabetes focus
limited innovation
weak methodology
unrealistic scope
poor feasibility
insufficient mentor or institutional support
unclear benefit to children living with diabetes

Specialties

Adolescent Medicine

Pediatrics

Endocrinology and Diabetes

Eligibility Requirements

FID-ISPAD Research Grant program is only open to applicants from non-profit institutions or groups of such institutions.

Sponsor Details

Sponsor Institute/Organizations: International Society for Pediatric and Adolescent Diabetes (ISPAD)

Sponsor Type: Corporate/Non-Profit

Address: Kurfürstendamm 71 10709 Berlin

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity